TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30365584

Group type: EXPERIMENTAL
Intervention: Ozenoxacin 1% cream, applied topically twice daily for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 27107547

Group type: COMPARATOR
Intervention: Unfiltered dilute diesel engine exhaust (DE)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Filtered dilute diesel engine exhaust
Number of subjects: 26

Group type: COMPARATOR
Intervention: Clean air
Number of subjects: 26
Study: 24387048

Group type: EXPERIMENTAL
Intervention: Complex intervention by an Advanced Practice Nurse (APN) using case management and counseling techniques
Number of subjects: 340

Group type: COMPARATOR
Intervention: Usual GP-care
Number of subjects: 340
Study: 22258156

Group type: EXPERIMENTAL
Intervention: bihemispheric tDCS and simultaneous occupational/physical therapy during the first 5-day period
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: bihemispheric tDCS and simultaneous occupational/physical therapy during the second 5-day period
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: bihemispheric tDCS and simultaneous occupational/physical therapy over two periods
Number of subjects: 10
Study: 19667033

Group type: EXPERIMENTAL
Intervention: Evidence‐based Practice for Improving Quality method (intervention group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (infection group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (pulmonary group)
Number of subjects: 0
Study: 17237312

Group type: EXPERIMENTAL
Intervention: Lean red meat intake (approximately 200 g/d)
Number of subjects: 60
Study: 16847402

Group type: EXPERIMENTAL
Intervention: vCP1452 + rgp120
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: vCP1452 alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12764338

Group type: EXPERIMENTAL
Intervention: Buffered tetracaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Plain tetracaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Difference between buffered and plain tetracaine
Number of subjects: 60
Study: 10368879

Group type: COMPARATOR
Intervention: Control group (n=6) - no drug treatment, only exercise training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Pretreatment group (n=6) - previously treated with fluvastatin 20 mg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Treatment group (n=6) - received fluvastatin 20 mg/day during training
Number of subjects: 18
Study: 9050100

Group type: EXPERIMENTAL
Intervention: 4% lignocaine solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 1908385

Group type: EXPERIMENTAL
Intervention: Buccal nitroglycerin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sublingual nitroglycerin
Number of subjects: 0
Study: 7046434

Group type: EXPERIMENTAL
Intervention: Combined hydrochlorothiazide (25 to 50 mg twice a day) and furosemide (increased doses of 320 to 480 mg/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Furosemide (160 to 240 mg/day)
Number of subjects: 8
Study: 29627267

Group type: EXPERIMENTAL
Intervention: Self-management modules (SelMa) group (3 hours)
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Self-management modules (SelMa) lecture (1 hour)
Number of subjects: 698

Group type: COMPARATOR
Intervention: Usual care (only disease-related education)
Number of subjects: 698
Study: 27677662

Group type: EXPERIMENTAL
Intervention: Enteral nutrition (53 patients, 74.6%)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nasogastric tube
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Percutaneous gastric tube
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dressing changes for fungating tumors (26 patients, 36.6%)
Number of subjects: 100
Study: 26178509

Group type: EXPERIMENTAL
Intervention: DN (docetaxel plus cisplatin)
Number of subjects: 124

Group type: COMPARATOR
Intervention: FP (nedaplatin plus cisplatin)
Number of subjects: 124
Study: 22720715

Group type: EXPERIMENTAL
Intervention: PRP/bovine-derived xenograft (BDX)
Number of subjects: 10

Group type: COMPARATOR
Intervention: BDX/collagen membrane
Number of subjects: 10
Study: 21992427

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS) with rechargeable pulse generator
Number of subjects: 132

Group type: COMPARATOR
Intervention: Re-operation
Number of subjects: 132
Study: 18456649

Group type: EXPERIMENTAL
Intervention: Ivermectin (24 mg)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 16041502

Group type: EXPERIMENTAL
Intervention: Intensive dental care protocol
Number of subjects: 34

Group type: COMPARATOR
Intervention: Limited dental care
Number of subjects: 34
Study: 12837434

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sildenafil (open-label phase)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sildenafil (2 years follow-up)
Number of subjects: 60
Study: 10890299

Group type: EXPERIMENTAL
Intervention: Health Consequences Expectancy Increase (HC)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Mood Management Expectancy Challenge (MM)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 123
Study: 8889399

Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI) - SI plus additional educational sessions stressing responsible drug use, including active referral in some cities.
Number of subjects: 2973

Group type: COMPARATOR
Intervention: Standard Intervention (SI) - HIV testing and counseling.
Number of subjects: 2973

Group type: EXPERIMENTAL
Intervention: Treatment (both SI and EI) compared to other interventions.
Number of subjects: 2973

Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI) with active referral.
Number of subjects: 2973
Study: 1686817

Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLX) treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6624524

Group type: EXPERIMENTAL
Intervention: Ankle arthrography combined with a stress inversion test
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Absence of peroneus sheath filling
Number of subjects: 102
Study: 31092172

Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells (MSCs) injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Optimized medical therapy (anti-TNF agents) with setons and additional surgical techniques
Number of subjects: 0
Study: 29223955

Group type: EXPERIMENTAL
Intervention: Preoperative HDL cholesterol concentration
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Long-term statin use
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Perioperative atorvastatin treatment
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Increasing long-term statin dose
Number of subjects: 391
Study: 25339309

Group type: EXPERIMENTAL
Intervention: Permanent iodine-125 seed implantation (PSI)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Combined seeds and external beam radiotherapy (COMB)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Overall survival (OS) and disease-specific survival (DSS)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: bRFS
Number of subjects: 312
Study: 24321006

Group type: EXPERIMENTAL
Intervention: Stable parental monitoring (84.9%)
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Declining parental monitoring (15.1%)
Number of subjects: 514
Study: 22931732

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis (IVT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 46
Study: 19389896

Group type: EXPERIMENTAL
Intervention: Elective termination of pregnancy (TOP) in asymptomatic women
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Elective termination of pregnancy (TOP) in symptomatic women
Number of subjects: 143

Group type: COMPARATOR
Intervention: Curettage vs no curettage in symptomatic women
Number of subjects: 143
Study: 17724088

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin PR (500 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Warfarin (7.5 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Warfarin (7.5 mg) + Ciprofloxacin PR (500 mg)
Number of subjects: 18
Study: 15339496

Group type: EXPERIMENTAL
Intervention: Kuhuang Injection, Shenmai Injection, Huangqi Liquid (treatment group)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Ribarvirin and Ganlixin Injection (control group)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: CGIDA (detection method)
Number of subjects: 101
Study: 11169084

Group type: EXPERIMENTAL
Intervention: Students viewing 'premature' (PL) infants
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Pre-clinical medical students
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Upper-level students
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Pre-clinical students
Number of subjects: 158

Group type: COMPARATOR
Intervention: Goal condition (students informed their judgments would be evaluated for accuracy)
Number of subjects: 158
Study: 9137798

Group type: EXPERIMENTAL
Intervention: Megestrol acetate 480 mg/day
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Megestrol acetate 160 mg/day
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 8025391

Group type: EXPERIMENTAL
Intervention: Cow's milk-based formula with 4 mg of iron/l
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cow's milk-based formula with 7 mg of iron/l
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breast-fed infants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cow's milk-based formula with selenium (10 micrograms/l)
Number of subjects: 0
Study: 3677508

Group type: EXPERIMENTAL
Intervention: Anatomic reduction (A) with sliding hip screw
Number of subjects: 18

Group type: COMPARATOR
Intervention: Medial displacement osteotomy (MD)
Number of subjects: 18
Study: 29709498

Group type: EXPERIMENTAL
Intervention: Toe-out gait modification
Number of subjects: 79

Group type: COMPARATOR
Intervention: Progressive walking
Number of subjects: 79
Study: 27871275

Group type: EXPERIMENTAL
Intervention: Cervical cerclage
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Cervical pessary (Arabin pessary)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (200 mg once daily)
Number of subjects: 170
Study: 26517583

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 354

Group type: COMPARATOR
Intervention: Usual activity
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid
Number of subjects: 354

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354
Study: 23594025

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 675

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 675
Study: 20499791

Group type: EXPERIMENTAL
Intervention: 4 gr/bid EAAs
Number of subjects: 32
Study: 18765330

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise (20 minutes per session, three times per week)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Non-exercisers
Number of subjects: 112
Study: 16615419

Group type: EXPERIMENTAL
Intervention: 201Tl chloride SPECT (TI‐SPECT)
Number of subjects: 41

Group type: COMPARATOR
Intervention: 99mTc‐MIBI SPECT (MIBI‐SPECT)
Number of subjects: 41
Study: 14713325

Group type: EXPERIMENTAL
Intervention: Therapeutic massage (MT)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Healing touch (HT)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Presence alone
Number of subjects: 230

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 230
Study: 10999810

Group type: EXPERIMENTAL
Intervention: DHEA 50 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: DHEA 25 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9118514

Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg UID
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 24-hour average BP
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Treatment-induced changes in average daytime and nighttime BPs
Number of subjects: 206

Group type: COMPARATOR
Intervention: Clinic BP
Number of subjects: 206
Study: 8419392

Group type: EXPERIMENTAL
Intervention: Two doses of cefotiam, given twelve hours apart
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study: 3025151

Group type: EXPERIMENTAL
Intervention: Various formulations of acyclovir
Number of subjects: 55
Study: 30866659

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 104607
Study: 28089606

Group type: EXPERIMENTAL
Intervention: Parasacral Transcutaneous Electrical Neural Stimulation (PTENS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Urotherapy and electrical stimulation placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: PTENS
Number of subjects: 16
Study: 25867608

Group type: EXPERIMENTAL
Intervention: Concomitant therapy (20 mg of esomeprazole, 1 g of amoxicillin, 500 mg of clarithromycin, and 500 mg of metronidazole, twice daily for 10 days)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Hybrid therapy (5-day dual therapy of 20 mg of esomeprazole and 1 g of amoxicillin, twice daily followed by 5-day quadruple therapy of 20 mg of esomeprazole, 1 g of amoxicillin, 500 mg of clarithromycin, and 500 mg of metronidazole, twice daily)
Number of subjects: 479
Study: 23769010

Group type: EXPERIMENTAL
Intervention: Street children (SG)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Regular children (CG)
Number of subjects: 196
Study: 20854305

Group type: EXPERIMENTAL
Intervention: Topical diclofenac sodium solution with DMSO
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diclofenac sodium gel
Number of subjects: 24
Study: 19242406

Group type: COMPARATOR
Intervention: 20 mg memantine
Number of subjects: 37

Group type: COMPARATOR
Intervention: 30 mg memantine
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 10 mg/kg memantine (in rats)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 20 mg/kg memantine (in rats)
Number of subjects: 37
Study: 17381970

Group type: EXPERIMENTAL
Intervention: Iron-fortified noodles
Number of subjects: 425

Group type: COMPARATOR
Intervention: Placebo (for iron-fortified noodles)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Mebendazole
Number of subjects: 425

Group type: COMPARATOR
Intervention: Placebo (for mebendazole)
Number of subjects: 425
Study: 14980936

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with V(T) = 12 or 15 mL/kg ideal body weight, zero end‐expiratory pressure
Number of subjects: 64

Group type: COMPARATOR
Intervention: Mechanical ventilation with V(T) = 6 mL/kg ideal body weight, positive end‐expiratory pressure of 10 cm H(2)O
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both ventilatory settings
Number of subjects: 64
Study: 11446564

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily (n = 59)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (n = 51)
Number of subjects: 110
Study: 9543191

Group type: EXPERIMENTAL
Intervention: Root-resective therapy with osseous recontouring and apically positioned flaps
Number of subjects: 72

Group type: COMPARATOR
Intervention: Surgical procedure identical to test procedure (without root resection)
Number of subjects: 72
Study: 8038256

Group type: EXPERIMENTAL
Intervention: Veterans Affairs envelope
Number of subjects: 901

Group type: COMPARATOR
Intervention: University envelope
Number of subjects: 901
Study: 3273486

Group type: EXPERIMENTAL
Intervention: Fentanyl 25 micrograms in 5 ml sterile normal saline
Number of subjects: 50

Group type: COMPARATOR
Intervention: 5 ml of saline
Number of subjects: 50
Study: 8494137

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine 0.25%
Number of subjects: 60
Study: 637072

Group type: EXPERIMENTAL
Intervention: Demonstration-training program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 30

Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 30
Study: 30646422

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg
Number of subjects: 445

Group type: COMPARATOR
Intervention: No aspirin
Number of subjects: 445
Study: 27798546

Group type: EXPERIMENTAL
Intervention: Corticosteroids at the start of fluid therapy (group C)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Corticosteroids at step 3 of treatment (group A)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Corticosteroids at step 3 of treatment with adrenal stimulation test (group B)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Combined group of A and B (group D)
Number of subjects: 128
Study: 25709044

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) for antenatal depression and anxiety
Number of subjects: 54
Study: 24300755

Group type: EXPERIMENTAL
Intervention: Clarithromycin 25 mg daily for 6 months
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Clarithromycin 25 mg daily for 3 months
Number of subjects: 66

Group type: COMPARATOR
Intervention: Basal therapy with mometasone furoate 400 mcg daily
Number of subjects: 66
Study: 21972623

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with infrared irradiation
Number of subjects: 160

Group type: COMPARATOR
Intervention: Indomethachin (25 mg orally, three times per day for 5 days)
Number of subjects: 160
Study: 19959590

Group type: EXPERIMENTAL
Intervention: Liquid very low energy diet (2.3 MJ/day) for seven weeks, followed by two weeks of gradual introduction of normal food, reaching 6.3 MJ/day at week 9.
Number of subjects: 63

Group type: COMPARATOR
Intervention: Usual diet during the nine weeks of follow‐up.
Number of subjects: 63
Study: 17095078

Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Plasmakinetic enucleation of the prostate
Number of subjects: 20
Study: 15491554

Group type: EXPERIMENTAL
Intervention: Manual placental removal (n=200)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Spontaneous placental separation (n=200)
Number of subjects: 400
Study: 11376303

Group type: EXPERIMENTAL
Intervention: Epoprostenol therapy (n = 201)
Number of subjects: 471

Group type: COMPARATOR
Intervention: Placebo (n = 235)
Number of subjects: 471
Study: 9834590

Group type: EXPERIMENTAL
Intervention: Thiamylal 5 mg.kg‐1 with vecuronium 0.1 mg.kg‐1
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thiamylal 3 mg.kg‐1 with additional thiamylal 4 mg.kg‐1 before intubation and vecuronium 0.1 mg.kg‐1
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol 2.5 mg.kg‐1 with vecuronium 0.1 mg.kg‐1
Number of subjects: 60
Study: 7926305

Group type: EXPERIMENTAL
Intervention: Beta-hydroxybutyrate (BOHB) infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactate infusion
Number of subjects: 0
Study: 2687006

Group type: EXPERIMENTAL
Intervention: Oxindanac 300 mg b.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Frusemide 40 mg b.d. with oxindanac
Number of subjects: 8

Group type: COMPARATOR
Intervention: Frusemide 40 mg b.d. with placebo
Number of subjects: 8
Study: 30525943

Group type: EXPERIMENTAL
Intervention: Flax+E1 (Flaxseed + 0.05% enzyme)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Flax+E2 (Flaxseed + 0.1% enzyme)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Flax (10% flax)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (0% flax)
Number of subjects: 72
Study: 28902073

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 220

Group type: COMPARATOR
Intervention: No treatment (standard of care)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Cryotherapy (among hrHPV+ women)
Number of subjects: 220

Group type: COMPARATOR
Intervention: No treatment (among hrHPV+ women)
Number of subjects: 220
Study: 26168736

Group type: EXPERIMENTAL
Intervention: Azithromycin treatment
Number of subjects: 72
Study: 23483214

Group type: EXPERIMENTAL
Intervention: Lower body progressive resistance training (PRT) for 12 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group maintaining usual daily activity
Number of subjects: 38
Study: 21600129

Group type: EXPERIMENTAL
Intervention: Target Controlled Infusion (TCI) of propofol at an initial plasma concentration of 2.0 µg/ml, titrated upwards by 0.5 µg/ml steps until loss of consciousness
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual Controlled Infusion (MCI) of propofol at 200 ml/h
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups received an infusion of remifentanil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 18304848

Group type: EXPERIMENTAL
Intervention: Massage programme with relaxation techniques
Number of subjects: 0

Group type: COMPARATOR
Intervention: Music with relaxation techniques (placebo)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study: 16420540

Group type: EXPERIMENTAL
Intervention: Glycerol cream
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Canola oil cream
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Bisabolol cream
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Carbomer cream
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Basic cream
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: IPP cream
Number of subjects: 2
Study: 12904840

Group type: COMPARATOR
Intervention: Calcium (1 g) and vitamin D (800 units of cholecalciferol) only (group 1: n=35)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Calcium/vitamin D and nutritional supplement drink providing 300 Kcal, 12 g protein, 11.6 g fat, and 36.8 g carbohydrate per carton (group 2: n=36)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Calcium/vitamin D and nutritional supplement drink (group 2)
Number of subjects: 71
Study: 11309029

Group type: EXPERIMENTAL
Intervention: Bexarotene capsules (300 mg/m2 per day)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Bexarotene gel
Number of subjects: 8
Study: 9926060

Group type: EXPERIMENTAL
Intervention: Community mental health services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive sector community services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-team model for acute and continuing care
Number of subjects: 0

Group type: COMPARATOR
Intervention: General community mental health model
Number of subjects: 0